Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co LtdfiledCriticalSumitomo Pharmaceuticals Co Ltd
Priority to JP6420182ApriorityCriticalpatent/JPS58180462A/ja
Publication of JPS58180462ApublicationCriticalpatent/JPS58180462A/ja
Publication of JPH0343261B2publicationCriticalpatent/JPH0343261B2/ja
Derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, et leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
Anthracycline glycosides a activite antitumorale, leur preparation, les composes intermediaires de cette preparation, et compositions et utilisation de ces substances.